So, why do the trial in Canada when the Americans have this program?
posted on
Aug 04, 2021 09:51PM
Yah, it ripped me when I read through this a few minutes ago! Thought we might be on this list, but...NADA!!!
So, according to sources that have been tapped...and dutifully reported here, we supposedly are still waiting for a few Canadian hospital committees to finish their reviews, and we supposedly are in some type of a queue waiting for our turn.
We've wasted potentially five months going up against Canadian bureaucracy/mediocrity, and the Americans have a program that could have sped this all up?
Or, do we give away the family farm by signing up here?
At a loss for words, other than it really sucks!
Does anybody know if we still did the additional animal studies request that Don brought up a few months ago?
COVID-19 Therapeutics Prioritized for Testing in Clinical Trials
Working in an unprecedented timeframe, the ACTIV public-private partnership has evaluated hundreds of available therapeutic agents with potential application for COVID-19, prioritized the most promising candidates, designed and harmonized adaptive master protocols for ACTIV clinical trials, and selected numerous NIH-supported networks to launch these clinical trials to test prioritized therapeutic candidates.
Master protocols allow coordinated and efficient evaluation of multiple investigational agents as they become available, but within the same clinical trial structure, across multiple study sites. Adaptive protocols swiftly weed out experimental drugs that do not demonstrate effectiveness and identify those that do. Adaptive master protocols reduce administrative burden and cost, provide a flexible framework to rapidly identify drugs that work, and rapidly move additional experimental agents into the trial.